-
Novartis Ordered To Recall Zelnorm From Market In Switzerland
Swiss Pharmaceutical Regulator States That Side Effect Risks Outweigh Benefits (Posted by Tom Lamb at DrugInjuryWatch.com) In a brief June 1, 2007 Wall Street Journal (WSJ) article it was reported that Switzerland’s pharmaceuticals regulator…
-
February 2007 Verdict In Hormone Replacement Therapy Trial Overturned in Favor of Wyeth
Court Grants Drug Company’s Motion To Set Aside Philadelphia Jury Verdict In Nelson v. Wyeth Lawsuit (Posted by Tom Lamb at DrugInjuryWatch.com) On May 31, 2007 Wyeth announced that the Philadelphia Court of Common…
-
Verdict For Plaintiff McCarrell In New Jersey Accutane Trial
Jury Awards $2.6 Million For Inflammatory Bowel Disease Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com)_____________________________________________________________________ Update: Accutane Retrial Verdict: Roche Ordered to Pay $25 Million to Accutane User By David Voreacos and John…
-
The Avandia Heart Attack Risk Was Raised To FDA Back In 2000; Will Agency Wait Until 2009 To Act?
In Comparison, Europe’s Regulators Had Glaxo Change Avandia Label In 2006 To Include Warning About Risk Of Cardiac Ischemic Events Such As Heart Attacks (Posted by Tom Lamb at DrugInjuryWatch.com) In a May 24,…
-
Glaxo’s Diabetes Drug Avandia May Cause Significant Heart Attack Risk
Avandia Might Have Prevented Diabetes In Some Patients, But Is This Benefit Offset By The Risk Of Heart Problems? (Posted by Tom Lamb at DrugInjuryWatch.com) On May 21, 2007 the Los Angeles Times published…
-
Merck’s May 2007 Report On Vioxx Trial Dates For Next Nine Months
Vioxx Trials Scheduled In CA, AL, FL, NV, WV, TX, and IL State Courts As Well As Federal Court MDL (Posted by Tom Lamb at DrugInjuryWatch.com) According to Merck & Co., as of May…
